Molecular Cytogenetics Market Research Report, Industry Analysis, Share, Growth and Forecast Till 2025

1. Global Molecular Cytogenetics Market Research Report and Forecast 2020 - 2025 www.imarcgroup.com Sales@imarcgroup.com +1-631-791-1145

2. About IMARC WHO WE ARE? • We are a leading market research firm with expertise in market intelligence and business research • We deliver high quality, well- knitted, meaningful studies • We excel at understanding and synergizing with the business priorities of our partners and delivering tailored solutions WHAT DO WE DO? • Market research and business insights • Competitive intelligence and benchmarking • Strategy consulting • Consumer surveys and feedback analysis • Social and rural research • Market entry strategy • Syndicated Reports WHAT DO WE COVER? • Food And beverages • Dairy and dairy products • Agriculture and farming • Chemicals and materials • FMCG • Paper and packaging • Healthcare • Machinery, electronics and semiconductors WHO DO WE SERVE? • Collaborating with fortune 500 companies and SMEs • Serving all major clients from different industry which include Chemical & Materials, Food & Beverages, Packaging, Healthcare, Automotive, Heavy Industries, Retail, etc.

3. What We Do Competitive Intelligence and Benchmarking At IMARC, we help customers determine a competitor’s brand image and perception in the marketplace as compared to other key players. Cost Modeling and Cost Forecasting A good cost model supports organizations during negotiations to build strong relationships with suppliers. Cost modelling and price forecasting services from IMARC ensure clients make informed decisions. Market Research & Business Insights To develop deep customer understanding, we employ a range of quantitative and qualitative marketing research approaches along with big data techniques that are both innovative and pragmatic Country Entry Strategy IMARC team drafts and implement an optimum country entry strategy for expanding business in the country. Our team of consultants deeply evaluates and strategize the market opportunities for our clients and accentuate the business in congruence with Government regulations, exports and imports scenario, demand supply gap analysis and many more. Consumer Survey & Feedback Reports Consumer profiling, survey with end consumers, collection of their feedback and deep analysis. Based on the analysis, strategic decisions to enter in a new region, launch of new product, improvising the existing services Consumer Survey & Feedback Reports Competitive Intelligence and Benchmarking Cost Modeling and Cost Forecasting Market Research & Business Insights Country Entry Strategy

4. REPORT OBJECTIVES & Highlight

5. Report Description According to the IMARC Group, Molecular cytogenetics includes the biomedical research of DNA mechanisms to investigate genetic mutations and disorders. It analyzes the structural and functional organization of the chromosomes and their nucleus, genomic variations, expression, evolution and abnormalities, particularly in medicinal and cancer-related genetics. Several techniques, such as DNA isolation, DNA amplification, gene screens, virtual karyotyping and fluorescence in-situ hybridization (FISH), are commonly used for molecular cytogenetics. These techniques are highly beneficial in diagnosing and treating various malignant tumors and hematological malignancies. Request for a free sample copy of this report: https://www.imarcgroup.com/molecular-cytogenetics-market/requestsample Market Trends: The growing prevalence of cancer and other genetic disorders is primarily driving the market growth. Furthermore, the widespread adoption of targeted therapies, such as FISH and Comparative Genomic Hybridization (CGH), that help in analyzing cancer progression stages and provide personalized treatment to the patient is further propelling the market. Additionally, several technological advancements have led to the development of improved consumables, reagents, kits, etc., that aid in generating accurate and reliable clinical-pathological test results, thereby driving the global market.

6. Report Description Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global molecular cytogenetics market report, along with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market based on region, product type, technology, application and end user. • Breakup by Product Type: • Instruments • Consumables • Software and Services • Others • Breakup by Technology: • Comparative Genomic Hybridization • Fluorescence in SITU Hybridization (FISH) • Immunohistochemistry • Karyotyping • Others • Breakup by Application: • Genetic Disorders • Oncology • Personalized Medicine • Others

7. Report Description • Breakup by End User: • Clinical and Research Laboratories • Hospitals and Pathology Laboratories • Pharmaceutical and Biotechnology Companies • Others • Breakup by Region: • North America • United States • Canada • Asia Pacific • China • Japan • India • South Korea • Australia • Indonesia • Others • Europe • Germany • France • United Kingdom • Italy • Spain

8. Report Description • • • • • • • Russia Others Latin America Brazil Mexico Others Middle East and Africa • Competitive Landscape: The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Agilent Technologies Inc., Applied Spectral Imaging Inc., Biological Industries, Bio-RAD Laboratories Inc., BioView Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Illumina Inc., Oxford Gene Technology, Perkinelmer Inc. and Quest Diagnostics Incorporated.

9. Report Description Explore Report Description: https://www.imarcgroup.com/molecular-cytogenetics-market Browse Related Report By IMARC Group Data Quality Tools Market: https://www.imarcgroup.com/data-quality-tools-market Big Data Software Market: https://www.imarcgroup.com/big-data-software-market 3D Printing Market: https://www.imarcgroup.com/3d-printing-market Cloud Security Software Market: https://www.imarcgroup.com/cloud-security-software-market

10. Report Description Key Questions Answered in This Report: •How has the global molecular cytogenetics market performed so far and how will it perform in the coming years? •What has been the impact of COVID-19 on the global molecular cytogenetics market? •What are the key regional markets? •What is the breakup of the market based on the product type? •What is the breakup of the market based on the technology? •What is the breakup of the market based on the application? •What is the breakup of the market based on the end user? •What are the various stages in the value chain of the industry? •What are the key driving factors and challenges in the industry? •What is the structure of the global molecular cytogenetics market and who are the key players? •What is the degree of competition in the industry?

11. Table of Contents

12. Table of Contents 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Molecular Cytogenetics Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Product Type 6.1 Instruments 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Consumables 6.2.1 Market Trends

13. Table of Contents 6.2.2 Market Forecast 6.3 Software and Services 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Others 6.4.1 Market Trends 6.4.2 Market Forecast 7 Market Breakup by Technology 7.1 Comparative Genomic Hybridization 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Fluorescence in SITU Hybridization (FISH) 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Immunohistochemistry 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Karyotyping 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Others 7.5.1 Market Trends 7.5.2 Market Forecast 8 Market Breakup by Application 8.1 Genetic Disorders

14. Table of Contents 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Oncology 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Personalized Medicine 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Others 8.4.1 Market Trends 8.4.2 Market Forecast 9 Market Breakup by End User 9.1 Clinical and Research Laboratories 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Hospitals and Pathology Laboratories 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Pharmaceutical and Biotechnology Companies 9.3.1 Market Trends 9.3.2 Market Forecast 9.4 Others 9.4.1 Market Trends 9.4.2 Market Forecast 10 Market Breakup by Region 10.1 North America

15. Table of Contents 10.1.1 United States 10.1.1.1 Market Trends 10.1.1.2 Market Forecast 10.1.2 Canada 10.1.2.1 Market Trends 10.1.2.2 Market Forecast 10.2 Asia Pacific 10.2.1 China 10.2.1.1 Market Trends 10.2.1.2 Market Forecast 10.2.2 Japan 10.2.2.1 Market Trends 10.2.2.2 Market Forecast 10.2.3 India 10.2.3.1 Market Trends 10.2.3.2 Market Forecast 10.2.4 South Korea 10.2.4.1 Market Trends 10.2.4.2 Market Forecast 10.2.5 Australia 10.2.5.1 Market Trends 10.2.5.2 Market Forecast 10.2.6 Indonesia 10.2.6.1 Market Trends 10.2.6.2 Market Forecast 10.2.7 Othrs

16. Table of Contents 10.2.7.1 Market Trends 10.2.7.2 Market Forecast 10.3 Europe 10.3.1 Germany 10.3.1.1 Market Trends 10.3.1.2 Market Forecast 10.3.2 France 10.3.2.1 Market Trends 10.3.2.2 Market Forecast 10.3.3 United Kingdom 10.3.3.1 Market Trends 10.3.3.2 Market Forecast 10.3.4 Italy 10.3.4.1 Market Trends 10.3.4.2 Market Forecast 10.3.5 Spain 10.3.5.1 Market Trends 10.3.5.2 Market Forecast 10.3.6 Russia 10.3.6.1 Market Trends 10.3.6.2 Market Forecast 10.3.7 Others 10.3.7.1 Market Trends 10.3.7.2 Market Forecast 10.4 Latin America 10.4.1 Brazil

17. Table of Contents 10.4.1.1 Market Trends 10.4.1.2 Market Forecast 10.4.2 Mexico 10.4.2.1 Market Trends 10.4.2.2 Market Forecast 10.4.3 Others 10.4.3.1 Market Trends 10.4.3.2 Market Forecast 10.5 Middle East and Africa 10.5.1 Market Trends 10.5.2 Market Breakup by Country 10.5.3 Market Forecast 11 SWOT Analysis 11.1 Overview 11.2 Strengths 11.3 Weaknesses 11.4 Opportunities 11.5 Threats 12 Value Chain Analysis 13 Porters Five Forces Analysis 13.1 Overview 13.2 Bargaining Power of Buyers 13.3 Bargaining Power of Suppliers 13.4 Degree of Competition 13.5 Threat of New Entrants 13.6 Threat of Substitutes

18. Table of Contents 14 Price Analysis 15 Competitive Landscape 15.1 Market Structure 15.2 Key Players 15.3 Profiles of Key Players 15.3.1 Abbott Laboratories 15.3.1.1 Company Overview 15.3.1.2 Product Portfolio 15.3.1.3 Financials 15.3.1.4 SWOT Analysis 15.3.2 Agilent Technologies Inc. 15.3.2.1 Company Overview 15.3.2.2 Product Portfolio 15.3.2.3 Financials 15.3.2.4 SWOT Analysis 15.3.3 Applied Spectral Imaging Inc. 15.3.3.1 Company Overview 15.3.3.2 Product Portfolio 15.3.4 Biological Industries 15.3.4.1 Company Overview 15.3.4.2 Product Portfolio 15.3.5 Bio-RAD Laboratories Inc. 15.3.5.1 Company Overview 15.3.5.2 Product Portfolio 15.3.5.3 Financials 15.3.5.4 SWOT Analysis

19. Table of Contents 15.3.6 BioView Inc. 15.3.6.1 Company Overview 15.3.6.2 Product Portfolio 15.3.7 Danaher Corporation 15.3.7.1 Company Overview 15.3.7.2 Product Portfolio 15.3.7.3 Financials 15.3.7.4 SWOT Analysis 15.3.8 F. Hoffmann-La Roche AG 15.3.8.1 Company Overview 15.3.8.2 Product Portfolio 15.3.8.3 SWOT Analysis 15.3.9 Illumina Inc. 15.3.9.1 Company Overview 15.3.9.2 Product Portfolio 15.3.9.3 Financials 15.3.9.4 SWOT Analysis 15.3.10 Oxford Gene Technology 15.3.10.1 Company Overview 15.3.10.2 Product Portfolio 15.3.10.3 Financials 15.3.11 Perkinelmer Inc. 15.3.11.1 Company Overview 15.3.11.2 Product Portfolio 15.3.11.3 Financials 15.3.11.4 SWOT Analysis

20. Table of Contents 15.3.12 Quest Diagnostics Incorporated 15.3.12.1 Company Overview 15.3.12.2 Product Portfolio 15.3.12.3 Financials

21. Report FAQs Team Profile Team Profile

22. Team Profile Growing team of 150+ employees with deep market knowledge Engineers and Post Graduates Account for 75% of our Team Post Graduates 30% Over 1000 Independent Consultants from different sectors Engineers 45% Talents from some of the top universities modelling specialists with unmatched expertise in quantitative research Individuals with experience in specific industries and having sound knowledge of targeted functional areas Non Engineering Graduates 15% Commercial and non-commercial relationships with some of the top research institutes Others 10%

23. Report FAQs Words From Client

24. Words From Client “We have been working with IMARC Group for over two years now. I must say that the word impossible doesn’t seems to appear in their dictionary,. These guys can provide data for any market in any country. I have been given them challenging assignments to work upon and have been quite impressed with their approach and results.” Procurement Technology Manager – Global FMCG Giant -Global “IMARC Group has great domain expertise and knowledge base provided all the inputs necessary for us to define the path forward and launch our diagnostic successfully in the market where other players were always afraid before investing.” -Vice President Marketing – European Diagnostic Company “We were really impressed with their research findings on the South India dairy market. The innovative idea suggested by them have given us altogether different aspect to look at the problem. We started with them on small project but now thinking on doing more strategic project with them.” -National Manager (Marketing) – Indian Diary Giant “IMARC Group helped us with the outsourcing of a major part of clinical trials to India. In the beginning we were skeptic of this idea. But the success achieved from this strategy is driving us to outsource other verticals of our business to low cost destinations” - Member of Board of Managing Director – Global Pharmaceutical Giant “Working with IMARC Group has been a great experience. They were able to provide us with a comprehensive business report on the India wastewater treatment market. The finding from the reports are played a major role in our business strategies and future decision making” -Senior Vice President – Major Indian Effluent Treatment Company

25. Report FAQs Report FAQs

26. Report FAQs 01 02 03 Do you provide market share information for a specific country/segment? Yes, we provide market share information and insights considering the scope. This service is provided as a part of customization requirements. My research requirement is very specific; can I customized the report? Yes, we provide customization of reports based on your requirements. It will be charged based on the scope of customization. Client have free access to pre-sales analyst briefs to discuss requirement and recommendations. How do you arrive at the market numbers? Our research methodology is a three cyclic process. It starts from information procurement from our inhouse database, primary research and secondary sources. The second step is data collection and analysis. The third step is data validation from industry experts, key players and other stakeholders. 04 05 I have a pre-defined budget. Can I buy chapters/sections of the report? We generally do not promote the sale of separate or individual segments from within a study, as it might fail to relay the actual meaning of the study or provide a holistic picture of the market. However, in special cases, select chapters are provided based on the client requirement. Do you offer post sales support? Yes, we offer post purchase analyst support for 4-6 weeks to our client in case they have any query within the scope of study.

27. Report FAQs 06 07 Who are your client? We have engaged 550+ clients across the globe. More than half of our client are re-engage us for additional reports and services How will I receive the report? The report in a PDF and Excel format will be sent to you electronically at your registered email address. Moreover, PPT and Word formats are also delivered to clients, on special requests. 08 09 How often does IMARC update studies? Research studies or reports are updated once in 6 months or a year depending on the traction & need. Please contact our sales team to inquire about a report update status. Will I have to pay for the post-sale customization needs? We offer our clients with a free 10% customization on the syndicated report. In case you have not availed this service as a pre-sale facility, we request you to share the requirements with our sales team. The research team post a feasibility will share the purview of the post-sale customization along with the price (if applicable) and the timeline.

28. SOME OF OUR KEY CUSTOMERS